Article Information
History
- May 18, 2020.
Article Versions
- Version 1 (May 8, 2020 - 02:09).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kyungmin Huh1,¶,
- Wonjun Ji2,¶,
- Minsun Kang3,¶,
- Jinwook Hong3,
- Gi Hwan Bae3,
- Rugyeom Lee3,
- Yewon Na3,
- Hyoseon Choi4,
- Seon Yeong Gong4 and
- Jaehun Jung3,4,*
- 1Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 2Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
- 3Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
- 4Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea
- ↵*Corresponding author:
Jaehun Jung, MD, PhD, Department of Preventive Medicine, Gachon University College of Medicine 38-13, Dokjeom-ro 3, Incheon, Korea, E-mail: eastside1st{at}gmail.com
↵¶ KH, WJ, and MK contributed equally to this work.
Posted May 18, 2020.
Association of previous medications with the risk of COVID-19: a nationwide claims-based study from South Korea
